Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts

Transplant Proc. 2002 Aug;34(5):1409-10. doi: 10.1016/s0041-1345(02)02908-1.

Authors

O Aramaki¹, T Takayama, T Yokoyama, S Takano, Y Akiyama, S Shibutani, N Shirasugi, S Kan, Y Ikeda, M Niimi

Affiliation

¹ Department of Surgery, Nihon University, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, Japan 173-8610.

PMID: 12176419
DOI: 10.1016/s0041-1345(02)02908-1

No abstract available

MeSH terms

Animals
Antithrombin III / administration & dosage
Antithrombin III / pharmacology*
Cell Survival / drug effects
Cytokines / biosynthesis
Graft Survival / drug effects*
Heart Transplantation / immunology*
Injections, Intravenous
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Time Factors
Transplantation, Homologous

Substances

Cytokines
Antithrombin III